These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 633085)

  • 1. Lidocaine effects on action potentials of Purkinje fibers from neonatal and adult dogs.
    Mary-Rabine L; Rosen MR
    J Pharmacol Exp Ther; 1978 Apr; 205(1):204-11. PubMed ID: 633085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Senescence-related changes in the responsiveness to ouabain of canine Purkinje fibers.
    Hewett K; Vulliemoz Y; Rosen MR
    J Pharmacol Exp Ther; 1982 Oct; 223(1):153-6. PubMed ID: 7120115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ouabain-induced changes in electrophysiologic properties of neonatal, young and adult canine cardiac Purkinje Fibers.
    Rosen MR; Hordof AJ; Hodess AB; Verosky M; Vulliemoz Y
    J Pharmacol Exp Ther; 1975 Jul; 194(1):255-63. PubMed ID: 1151753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction of Vmax by QX-314 and benzocaine in neonatal and adult canine cardiac Purkinje fibers.
    Spinelli W; Danilo P; Rosen MR
    J Pharmacol Exp Ther; 1988 Apr; 245(1):381-7. PubMed ID: 3361451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of lidocaine and on slow response and depressed fast response action potentials of canine cardiac Purkinje fibers.
    Brennan FJ; Cranefield PF; Wit AL
    J Pharmacol Exp Ther; 1978 Feb; 204(2):312-24. PubMed ID: 621666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequency-dependent actions of phenytoin in adult and young canine Purkinje fibers.
    Spinelli W; Rosen MR
    J Pharmacol Exp Ther; 1986 Sep; 238(3):794-801. PubMed ID: 3746664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of quinidine on the transmembrane potentials of young and adult canine cardiac Purkinje fibers.
    Morikawa Y; Rosen MR
    J Pharmacol Exp Ther; 1986 Mar; 236(3):832-7. PubMed ID: 3950873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of therapeutic concentrations of diphenylhydantoin on transmembrane potentials of normal and depressed Purkinje fibers.
    Rosen MR; Danilo P; Alonso MB; Pippenger CE
    J Pharmacol Exp Ther; 1976 Jun; 197(3):594-604. PubMed ID: 932992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiarrhythmic effects of ethmozin in cardiac Purkinje fibers: suppression of automaticity and abolition of triggering.
    Dangman KH; Hoffman BF
    J Pharmacol Exp Ther; 1983 Dec; 227(3):578-86. PubMed ID: 6317840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interval-dependent effects of lidocaine on conduction in canine cardiac Purkinje fibers: experimental observations and theoretical analysis.
    Nattel S
    J Pharmacol Exp Ther; 1987 Apr; 241(1):275-81. PubMed ID: 3572789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electrophysiological effects of mexiletine (Kö1173) on ovine cardiac Purkinje fibers.
    Weld FM; Bigger JT; Swistel D; Bordiuk J; Lau YH
    J Pharmacol Exp Ther; 1979 Aug; 210(2):222-8. PubMed ID: 458628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electrophysiological effects of ACC-9358, a novel class I antiarrhythmic agent, on isolated canine Purkinje fibers and ventricular muscle.
    Brown BS
    J Pharmacol Exp Ther; 1989 Feb; 248(2):552-8. PubMed ID: 2918472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use-dependent effects of lidocaine in neonatal and adult ventricular myocardium.
    Jeck CD; Rosen MR
    J Pharmacol Exp Ther; 1990 Nov; 255(2):738-43. PubMed ID: 2173756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of the potassium channel activator, BRL 34915, on the action potential characteristics of canine cardiac Purkinje fibers.
    Bril A; Man RY
    J Pharmacol Exp Ther; 1990 Jun; 253(3):1090-6. PubMed ID: 2359018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiac electrophysiologic effects of lidocaine and bupivacaine.
    Moller RA; Covino BG
    Anesth Analg; 1988 Feb; 67(2):107-14. PubMed ID: 3341563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Developmental changes in action potential duration, refractoriness, and conduction in the canine ventricular conducting system.
    Untereker WJ; Danilo P; Rosen MR
    Pediatr Res; 1984 Jan; 18(1):53-8. PubMed ID: 6701034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Local anesthetic and negative chronotropic effects of diltiazem on canine cardiac Purkinje fibers.
    Dangman KH; Ziam S; Miura DS
    Am Heart J; 1989 Jun; 117(6):1271-7. PubMed ID: 2729055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rate-dependent effects of lidocaine on His-Purkinje conduction in the intact neonatal heart--characterization and amplification by N-acetylprocainamide.
    Dise TL; Stolfi A; Clarkson CW; Pickoff AS
    J Pharmacol Exp Ther; 1991 Nov; 259(2):535-42. PubMed ID: 1719192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of lidocaine on components of excitability in long mammalian cardiac Purkinje fibers.
    Arnsdorf MF; Bigger JT
    J Pharmacol Exp Ther; 1975 Nov; 195(2):206-15. PubMed ID: 1185592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequency-dependent effects of antiarrhythmic drugs on action potential duration and refractoriness of canine cardiac Purkinje fibers.
    Nattel S; Zeng FD
    J Pharmacol Exp Ther; 1984 Apr; 229(1):283-91. PubMed ID: 6707943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.